Last reviewed · How we verify
Inert Compound
At a glance
| Generic name | Inert Compound |
|---|---|
| Sponsor | Sheppard Pratt Health System |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Acute Effects of Nicotinamide Riboside on Polysomnography-Measured Sleep Structure in Healthy Adults (NA)
- Evaluation of an Ayurvedic Herbal Compound Compared to Vitamins C+E and Placebo on Vascular Function in High-Risk Subjects (NA)
- Effects of β-alanine and Sodium Bicarbonate Supplementation on Physical Capacity and Biochemical Markers Concentrations (PHASE3)
- Treatment of Long CoronaVirus Disease (COVID) (TLC) Feasibility Trial (PHASE3)
- Supplemental Hydrogen Plus PQQ for Mitochondrial Biomarkers and Brain Function in Elderly With Mild Cognitive Impairment (NA)
- Creatine and GAA for Brain Oxygenation (NA)
- Pre-probiotic Supplementation for Post-covid Fatigue Syndrome (NA)
- Probiotics to Prevent Relapse After Hospitalization for Bipolar Depression (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Inert Compound CI brief — competitive landscape report
- Inert Compound updates RSS · CI watch RSS
- Sheppard Pratt Health System portfolio CI